|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 269.95 USD | -4.22% |
|
-3.35% | +17.84% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Development and Commercialization of Molecular Testing Services | 625M | 820M | 1.08B | 1.7B | 2.31B | |||||
Total Assets | 1.24B | 1.39B | 1.44B | 1.66B | 2.4B | |||||
Interest Expense | -8.3M | -9.32M | -12.64M | -10.68M | -4.07M | |||||
Income Tax Expense | 618K | 978K | 271K | 695K | -59.93M | |||||
CAPEX | -49.59M | -47.7M | -39.2M | -66.42M | -106M | |||||
EBT | -471M | -547M | -435M | -190M | -268M | |||||
D&A | 10.15M | 16.5M | 21.7M | 27.47M | 38.48M | |||||
Operating Income | -468M | -541M | -446M | -222M | -310M | |||||
Net Income | -472M | -548M | -435M | -190M | -208M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 591M | 786M | 1.05B | 1.66B | 2.26B | |||||
Total Assets | 1.24B | 92.45M | 111M | 1.66B | 2.4B | |||||
Europe, Middle East, India, Africa | 20.43M | 16.64M | 22.81M | 23.88M | 24.48M | |||||
Americas, Excluding U.S. | 4.05M | 3.7M | 4.91M | 6.62M | 9.35M | |||||
Asia Pacific and Other | 10.14M | 14.03M | 7.22M | 8.66M | 8.01M |
- Stock Market
- Stocks
- NTRA Stock
- Financials Natera, Inc.
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition